BioXcel Therapeutics (BTAI) Other Non-Current Assets (2018 - 2025)

BioXcel Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $87000.0 for Q1 2025.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $87000.0 in Q1 2025; TTM through Mar 2025 was $87000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at $87000.0, changed 0.0% from the prior year.
• Other Non-Current Assets was little changed at $87000.0 in Q1 2025 per BTAI's latest filing, from $87000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.8 million in Q3 2021 and bottomed at $86000.0 in Q4 2021.
• The 5-year median for Other Non-Current Assets is $87000.0 (2023), against an average of $556764.7.
• Across the five-year window, Other Non-Current Assets jumped 3096.08% in 2021 and tumbled 90.59% in 2023, its largest moves.
• Year by year, Other Non-Current Assets stood at $86000.0 in 2021, then jumped by 975.58% to $925000.0 in 2022, then tumbled by 90.59% to $87000.0 in 2023, then changed by 0.0% to $87000.0 in 2024, then changed by 0.0% to $87000.0 in 2025.
• Per Business Quant, the three latest BTAI Other Non-Current Assets figures stand at $87000.0 (Q1 2025), $87000.0 (Q4 2024), and $87000.0 (Q3 2024).